Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Glycopyrronium Bromide, Formoterol And Beclometasone (Atc Code: R03al09).

Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Glycopyrronium Bromide, Formoterol And Beclometasone (Atc Code: R03al09).. The Aok Lower Saxony. The Health Insurance Company Intends To Conclude Non-Exclusive Drug Discount Contracts For The Active Ingredient Combination Of Glycopyrronium Bromide, Formoterol And Beclometasone (Atc Code: R03al09) With As Many Market Participants As Possible (Pharmaceutical Companies Or Communities Of Pharmaceutical Companies) In The So-Called “Open-House Model” Until Exclusive Contracts Come Into Force After A Public Tender In Accordance With The Regulations Of Part 4 Of The Gwb. The Aok Lower Saxony Will Not Make A Selection Decision And Submit An Identical Contract Offer To Every Interested Pharmaceutical Company. In The Open-House Model, The Contract Contents, Conditions And Access Procedures Are The Same - Individual Negotiations Are Generally Not Carried Out. The Earliest Contract Start Date Is August 1St, 2026. A Contract Can Be Concluded Within The Twenty-Four-Month Period On The First Of Each Month. Aok Niedersachsen Reserves The Right To Replace The Non-Exclusive Open-House Discount Contracts With Exclusive Discount Contracts When Advertised Exclusive Discount Contracts Come Into Force, I.E. The Open-House Contracts End Automatically Afterwards, Exclusive Discount Agreements Usually Come Into Force Six To Eight Months After The Publication Of The Corresponding Tender Notice In The Supplement To The Official Journal Of The European Union. The Future Contractual Partners In The Open-House Model Are Requested To Regularly Inform Themselves About These Tender Notices In The Supplement To The Official Journal Of The European Union. Interested Pharmaceutical Companies Can Request The Contract Documents And The Contractual Conditions At The Contact Address Given Under I.1). Contracts For The Active Ingredient Combination Of Glycopyrronium Bromide, Formoterol And Beclometasone (Atc Code: R03al09) Will Be Concluded For The First Time With Effect From August 1, 2026. Interested Parties Who Would Like To Become Contractual Partners On This Date Must Submit The Contractual Documents To The Address Specified In The Contractual Documents By June 29, 2026. It Depends On Access To Aok Niedersachsen. Later Contracts Are Possible During The Twenty-Four-Month Maximum Term On The First Of Each Month. From An Organizational Point Of View, The Aok Generally Needs A Lead Time Of 35 Calendar Days To Carry Out The Necessary Work, E.G. B. To Be Able To Ensure Contract Reporting In The Lauer-Taxe®. The Exact Input F